Phase II study of temozolomide and thalidomide in patients with metastatic neuroendocrine tumors. - Kulke,MH.; Stuart,K.; Enzinger,PC.; Ryan,DP.; Clark,JW.; Muzikansky,A.; Vincitore,M.; Michelini,A.; Fuchs,CS. (J Clin Oncol, 2006)